Albany, NY (PRWEB) August 01, 2014
Oxford Gene Technology (OGT) is a biotechnology company. The company develops biomarkers. Its products include CytoSure heamatological cancer +SNP Array, CytoSure ISCA arrays, CytoSure ISCA +SNP Array, CytoSure ISCA UPD array, CytoSure ISCA sample tracking spike-ins and CytoSure syndrome Plus v2 array. OGT offers services, such as targeted sequencing services, SureSeq Solid Tumour Panel Sequencing Service, RNA-Seq service, miRNA analysis, gene expression analysis, cytosure services and aCGH for CNV analysis. The companys customers include Agilent Technologies, University of Cambridge, Cancer Research UK, Alberta Childrens Hospital, Bioarray and many more. OGT is headquartered in Begbroke, Oxfordshire, the UK.
To view the table of contents for this market research report please visit :http://www.researchmoz.us/oxford-gene-technology-product-pipeline-analysis-2014-update-report.html.
This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Oxford Gene Technology
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
All Repoers of this Category Here: http://www.researchmoz.us/medical-equipments-market-reports-109.html
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
Website at http://www.researchmoz.us/
Get More Market Research Report : https://www.linkedin.com/today/author/227772465
Read the full story at http://www.prweb.com/releases/2014/08/prweb12065890.htm.
Related medicine news :1
Copyright©2014 Vocus, Inc.
All rights reserved
. Major EPSRC Programme Grant to support new Oxford Centre for Drug Delivery Devices2
. Oxford University Press releases Trans Bodies, Trans Selves3
. Oxford City Football Club, Inc. (OTCQB:OXFC) Defeats Worcester City FC 2-0.4
. Thomas Anthony Guerriero, CEO Oxford City Football Club (OTCQB: OXFC), Featured on the Cover of Opportunist Magazine5
. 1-2-3 Magic, by ParentMagic, Given 5 Stars, Highly Recommend Rating by Experts in “Self-Help That Works” by Oxford University Press6
. USC, Oxford researchers find high fructose corn syrup-global prevalence of diabetes link7
. Oxford University Press acquires American Journal of Hypertension8
. Oxford University Press acquires joint ownership of Journal of Surgical Case Reports9
. Oxford University Press launches Evolution, Medicine, and Public Health10
. Market America 11
. SHOP.COM Set to Unveil Technology Enhancements and New Products at the 2014 International Convention